The antitumor effect of suicide gene therapy using Bifidobacterium infantis-mediated herpes simplex virus thymidine kinase/ganciclovir in a nude mice model of renal cell carcinoma

Urology

Volumn 84, Issue 4, 2014, Pages 982.e15-982.e20

  Xiao, Xiao ^a   Jin, Ren ^a   Li, Jiang ^a   Bei, Yu ^b   Wei, Tang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHENGDU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS MEDIATED HERPES SIMPLEX VIRUS THYMIDINE KINASE; CASPASE 3; DEOXYRIBONUCLEOTIDE; DEOXYURIDINE PHOSPHATE; DNA NUCLEOTIDYLEXOTRANSFERASE; GANCICLOVIR; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL XL; SODIUM CHLORIDE; THYMIDINE KINASE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTEREMIA; BEHAVIOR CHANGE; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CANCER SURGERY; CANCER TISSUE; CARCINOMA CELL; CARCINOMA CELL LINE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; HERPES SIMPLEX VIRUS; KIDNEY CARCINOMA; MENTAL HEALTH; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SUICIDE GENE THERAPY; TREATMENT OUTCOME; WEIGHT REDUCTION; WESTERN BLOTTING;

EID: 84922057919     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.05.020     Document Type: Article

References (30)

1. C.S. Ng, C.G. Wood, and P.M. Silverman Renal cell carcinoma: diagnosis, staging, and surveillance AJR Am J Roentgenol 191 2008 1220 1232
2. D. Mooney, R. Paluri, and A. Mehta Update in systemic therapy of urologic malignancies Postgrad Med 126 2014 44 54
3. R.J. Motzer, N. Agarwal, and C. Beard Kidney cancer J Natl Compr Canc Netw 9 2011 960 977
4. H.L. Kong, and R.G. Crystal Gene therapy strategies for tumor antiangiogenesis J Natl Cancer Inst 90 1998 273 286
5. K. Yazawa, M. Fujimori, and J. Amano Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors Cancer Gene Ther 7 2000 269 274
6. P.W. Vaupel B.A. Teicher, Oxygenation of solid tumors in drug resistance in oncology 1993 Marcel Dekker New York 53 85
7. S. Ruiz-Moyano, N. Tao, and M.A. Underwood Rapid discrimination of Bifidobacterium animalis subspecies by matrix-assisted laser desorption ionization-time of flight mass spectrometry Food Microbiol 30 2012 432 437
8. N.T. Kimura, S. Taniguchi, and K. Aoki Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration Cancer Res 40 1980 2061 2068
9. C. Yi, Y. Huang, and Z.Y. Guo Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma Acta Pharmacol Sin 26 2005 629 634
10. Li Zj, H. Zhu, and B.Y. Ma Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice BMC Cancer 12 2012 155
11. W. Tang, Y. He, and S. Zhou A novel bifidobacterium infantis mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer J Exp Clin Cancer Res 28 2009 155 161
12. H. Zhu, Z. Li, and S. Mao Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium infantis on Lewis lung cancer in mice Cancer Gene Ther 18 2011 884 896
13. B. Hu, L. Kou, and C. Li Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth Cancer Gene Ther 16 2009 655 663
14. T. Wirth, N. Parker, and S. Ylä-Herttuala History of gene therapy Gene 525 2013 162 169
15. S.W. Kim, S.J. Kim, and S.H. Park Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK Clin Cancer Res 19 2013 415 427
16. L.J. Jia, and Z.C. Hua Development of bacterial vectors for tumor-targeted gene therapy Methods Mol Biol 542 2009 131 154
17. M. Fujimori, J. Amano, and S. Taniguchi The genus Bifidobacterium for cancer gene therapy Curr Opin Drug Discov Devel 5 2002 200 203
18. D. Chinnasamy, Z. Yu, and M.R. Theoret Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice J Clin Invest 120 2010 3953 3968
19. Y. Liu, M. Zhou, and D. Luo Bacteria-mediated in vivo delivery of quantum dots into solid tumor Biochem Biophys Res Commun 425 2012 769 774
20. X. Yin, B. Yu, and Z. Tang Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer Cancer Gene Ther 20 2013 77 81
21. B. Golankiewicz, and T. Ostrowski Tricyclic nucleoside analogues as antiherpes agents Antiviral Res 71 2006 134 140
22. D. Portsmouth, J. Hlavaty, and M. Renner Suicide genes for cancer therapy Mol Aspects Med 28 2007 4 41
23. W. Hamel, L. Magnelli, and V.P. Chiarugi Herpes simplex virus kinase/gancicliv-mediated apoptotic death of bystander cells Cancer Res 56 1996 8699 8704
24. C. Beltinger, S. Fulda, and H. Walczak TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells Cancer Gene Ther 9 2002 372 381
25. N.N. Danial, and S.J. Korsmeyer Cell death: critical control points Cell 116 2004 205 219
26. H.L. Pahl Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
27. S.J. Korsmeyer BCL-2 gene family and the regulation of programmed cell death Cancer Res 59 7 Suppl 1999 1693s 1700s
28. D.M. Monsalve, T. Merced, and I.F. Fernandez Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression Cell Death Dis 4 2013 e513
29. S.W. Muchmore, M. Sattler, and H. Liang X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death Nature 381 1996 335 341
30. T.L. Lee, J. Yeh, and J. Friedman A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas Int J Cancer 122 2008 1987 1998